GLP-1 Drugs Before Surgery: What to Tell the Anesthesia Team

Tell the anesthesia team about semaglutide, tirzepatide and other GLP-1 medicines before any procedure involving anesthesia or deep sedation. Current ASA patient guidance says most people can continue their medication, while the team may recommend additional precautions for people at higher risk. Do not replace that assessment with a universal instruction to stop for a week¹.

The concern is delayed stomach emptying: food or fluid may remain in the stomach despite a usual fasting interval, creating an aspiration concern during anesthesia. Zepbound's prescribing information includes a warning about pulmonary aspiration during general anesthesia or deep sedation².

Why a weight-loss drug matters to anesthesia

A preoperative medication list helps the team plan for more than interactions between medicines. With GLP-1 treatment, the question includes what may be in the stomach when protective reflexes are reduced during a procedure. That is why the anesthesia team needs to know the exact drug even when a procedure seems unrelated to weight management.

The label reports aspiration events but does not establish that every GLP-1 user will aspirate or that one interruption interval prevents the problem. A warning should trigger a coordinated assessment, not an assumption that the medication must always be stopped or can always be continued without discussion².

Give the information at the scheduling or preoperative visit. The morning of the procedure is a poor time to discover a difference between a clinic's generic fasting handout and the instructions intended for your medication and symptoms.

What changed from blanket stopping advice?

ASA's patient resource describes the multisociety approach issued in 2024: most patients can keep taking their GLP-1 medicine, with additional measures considered for higher-risk situations. Those situations include the dose-escalation period, significant gastrointestinal symptoms, higher doses and other conditions that slow stomach emptying¹.

This is a risk-based plan. It does not mean that every hospital uses the same preparation instructions, or that patients should overrule the team responsible for their procedure. If you receive conflicting instructions, ask the prescriber and procedural team to reconcile them rather than choosing whichever online recommendation seems easiest.

A guideline's publication year matters too. Search engines can surface older stopping advice beside newer guidance. Check which document a recommendation comes from and whether the person giving your instructions knows your current dose, formulation and symptom history.

The information your team needs

Prepare a short medication record with the drug name, dose, dosing day, last dose taken, route and reason for treatment. Include the prescribing clinician's contact information and whether the product is a branded pen, a vial or another formulation. A brand nickname alone can leave the team guessing about the actual medicine.

Describe recent dose changes and symptoms plainly. Tell them about nausea, vomiting, feeling full unusually long, abdominal discomfort or difficulty keeping food and fluids down. Reporting symptoms is more useful than deciding for yourself that they are merely normal side effects. Our tirzepatide side-effect guide provides context, but the procedural team needs your actual experience.

Include other medications and conditions on the same record. A preoperative plan should account for the whole clinical picture, particularly if a change could affect diabetes management. The person managing the GLP-1 prescription and the person planning anesthesia need the same information.

Extra precautions are selected by the team

Depending on the situation, the team may discuss a liquid-only diet before the procedure, changes to the anesthesia plan, ultrasound assessment of the stomach or a delay until a temporary risk factor has improved. ASA discusses these as ways of reducing risk in selected patients¹.

Do not improvise a fasting or liquid-diet protocol from a summary article. Ask exactly which liquids are allowed, when they stop and how the instructions interact with your other medications. An instruction to follow liquids for part of the preparation does not answer every fasting question.

If a procedure is delayed, ask what must happen before it can be rescheduled and who will reassess it. A useful explanation identifies the concern and the next step, rather than leaving you with the impression that taking a GLP-1 makes future procedures impossible.

If the team tells you to hold the medication

Request an explicit plan: which dose to omit, how other conditions will be managed, whom to call if symptoms change, and who will advise when treatment resumes. This article cannot determine the right interval for an individual procedure or provide a restart dose.

The reason for treatment matters. A person using the medicine for diabetes may need a plan for glucose management during an interruption. Someone using it for obesity may have a different set of concerns, but still needs coordinated instructions. Avoid changing another medication to compensate unless the treating clinician directs it.

If you already took the dose, tell the team. Concealing it to avoid cancellation prevents an informed decision. They can assess the procedure, urgency, symptoms and available precautions; an online article cannot do that assessment for them.

Sedation outside a hospital still counts

Ask about the plan for endoscopy, colonoscopy, dental sedation and other procedures where anesthesia or deep sedation may be used. The important question is the level of sedation and the team's assessment, rather than whether the procedure is labeled major surgery.

Bring the medication list even if the appointment is in a freestanding center. Ask who provides anesthesia or sedation and how to send them the information before the procedure. When bowel preparation or a special diet is already planned, clarify how the medication instructions fit with that preparation instead of assuming one replaces the other.

In an emergency, tell the treating team when you last ate, drank and took the medication. Do not delay urgent care to complete a self-directed drug washout. The clinical team can incorporate that information into the immediate plan.

Planning the return to training

The procedure, recovery instructions and ability to eat and drink determine the return-to-activity discussion. Resuming a medication is not the same decision as resuming hard exercise. Ask separately about the drug, food intake, hydration, lifting restrictions and any warning symptoms after the procedure.

Do not use appetite suppression as a reason to rush a post-procedure calorie deficit. Give the clinician a realistic description of your training goals and the food you can tolerate. A care plan that sounds reasonable on paper may need adjustment when meals or activity are restricted.

For longer interruptions, the withdrawal and maintenance guide explains what trials can say about weight regain. It does not establish a restart schedule after anesthesia; that remains an individual prescribing question.

Questions worth resolving before procedure day

Ask who owns the final medication instructions, whether your recent dose escalation changes the plan, and what to do if stomach symptoms appear after the preoperative visit. Confirm that written instructions describe the current plan rather than a generic handout from an older policy.

Also ask how to contact the team outside routine hours and whether a change in the procedure date changes the medication plan. These details are administrative, but they make a clinical recommendation usable. A clear plan is one that you can follow without filling in missing steps yourself.

The practical message is to communicate early and use the instructions for your procedure. Most patients can continue a GLP-1 under current risk-based guidance, but that statement is the beginning of the conversation, not personal clearance for anesthesia.